Pharmexcil: India will achieve the target of 17 billion dollars of pharma exports by the end of 2015
Indian Pharmexcil recently announced awards for outstanding export performances in the bulk drugs and formulations category, for the year 2013-14. Of the 150 applications, Lupin, Aurobindo and Mylan bagged top awards for their exceptional performance.
Mumbai- based Lupin received the ‘all-round performer' award, while Aurobindo Pharma and Mylan Laboratories have been judged as leading bulk drugs and formulations exporters respectively.
The award for mid-range emerging companies were given to Laurus Labs and Glenmark Pharmaceuticals. Apotex research and Sanofi India were recognized as mid-range formulations doing excellent export business.
Fourrts (India) Laboratories has bagged an award under emerging company category. The award for leading exporters of biopharmaceuticals was received by Hyderabad-based Biological E.
Further Suven Life Sciences received an award as the leading contract research and manufacturer for the year 2013-14. Sami Labs and ACG- Associated Capsules have bagged outstanding export awards under herbals and excepients categories, while Omni Active Health Technologies, has bagged an award under the Nutraceuticals category.